DE69825888D1 - Diagnostisches verfahren der alzheimer-erkrankung - Google Patents

Diagnostisches verfahren der alzheimer-erkrankung

Info

Publication number
DE69825888D1
DE69825888D1 DE69825888T DE69825888T DE69825888D1 DE 69825888 D1 DE69825888 D1 DE 69825888D1 DE 69825888 T DE69825888 T DE 69825888T DE 69825888 T DE69825888 T DE 69825888T DE 69825888 D1 DE69825888 D1 DE 69825888D1
Authority
DE
Germany
Prior art keywords
alzheimer
disease
diagnostic procedure
diagnostic
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69825888T
Other languages
English (en)
Other versions
DE69825888T2 (de
Inventor
Marie-Christin Chartier-Harlin
Jean-Charles Lambert
Philippe Amouyel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut Pasteur de Lille
Application granted granted Critical
Publication of DE69825888D1 publication Critical patent/DE69825888D1/de
Publication of DE69825888T2 publication Critical patent/DE69825888T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
DE69825888T 1997-07-01 1998-06-30 Diagnostisches verfahren der alzheimer-erkrankung Expired - Lifetime DE69825888T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9708284 1997-07-01
FR9708284A FR2765591B1 (fr) 1997-07-01 1997-07-01 Procede de diagnostic de la maladie d'alzheimer
PCT/FR1998/001394 WO1999001574A1 (fr) 1997-07-01 1998-06-30 Procede de diagnostic de la maladie d'alzheimer

Publications (2)

Publication Number Publication Date
DE69825888D1 true DE69825888D1 (de) 2004-09-30
DE69825888T2 DE69825888T2 (de) 2005-11-17

Family

ID=9508696

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69825888T Expired - Lifetime DE69825888T2 (de) 1997-07-01 1998-06-30 Diagnostisches verfahren der alzheimer-erkrankung

Country Status (8)

Country Link
US (1) US6391553B1 (de)
EP (1) EP0983391B1 (de)
JP (1) JP4358311B2 (de)
AU (1) AU8346498A (de)
CA (1) CA2295865C (de)
DE (1) DE69825888T2 (de)
FR (1) FR2765591B1 (de)
WO (1) WO1999001574A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU695641B2 (en) * 1993-09-20 1998-08-20 Novartis Ag Human metabotropic glutamate receptor subtypes (HMR4, HMR6, HMR7) and related DNA compounds
EP1113081A1 (de) * 1999-12-28 2001-07-04 Institut Pasteur De Lille Zusammenhang des bekannten Gens CP2/LSF/LBP-1 mit Alzheimer
US20060160079A1 (en) * 2002-08-07 2006-07-20 Lane Roger M Methods for the treatment of dementia based on apo e genotype
JP5241994B2 (ja) 2004-11-05 2013-07-17 戸田工業株式会社 酸化チタン粒子粉末及び光触媒
EP1859056A2 (de) * 2005-01-31 2007-11-28 Perlegen Sciences, Inc. Genetische grundlage von morbus alzheimer sowie diagnose und behandlung davon
EP1910569A4 (de) * 2005-06-17 2009-08-05 Genizon Biosciences Inc Genkarte der mit langlebigkeit assoziierten menschlichen gene
CN102471800A (zh) * 2009-07-03 2012-05-23 加的夫大学学院咨询有限公司 阿尔茨海默病的诊断和治疗
WO2011024035A1 (en) * 2009-08-27 2011-03-03 Institut Pasteur De Lille Method for determining the risk of occurrence of alzheimer's disease
WO2013130654A1 (en) 2012-02-29 2013-09-06 Coyote Pharmaceuticals, Inc. Gga and gga derivatives, compositions thereof and methods for treating neurodegenerative diseases including paralysis including them
US9119808B1 (en) 2012-10-08 2015-09-01 Coyote Pharmaceuticals, Inc. Treating neurodegenerative diseases with GGA or a derivative thereof
US20140178877A1 (en) * 2012-12-20 2014-06-26 Roche Molecular Systems, Inc. Labeled Oligonucleotide Probes Used for Nucleic Acid Sequence Analysis
CN107636171A (zh) * 2015-03-04 2018-01-26 威拉赛特公司 使用表达水平和序列变体信息评估疾病发生或复发风险的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0625212B1 (de) * 1992-10-13 2004-03-24 Duke University VERFAHREN ZUM nachweis der Alzheimer Krankheit
CA2111503A1 (en) * 1993-12-15 1995-06-16 Mcgill University Apolipoprotein e polymorphism and alzheimer's disease
FR2716894B1 (fr) * 1994-03-07 1996-05-24 Pasteur Institut Marqueurs génétiques utilisés conjointement pour le diagnostic de la maladie d'Alzheimer, méthode et kit de diagnostic.
GB9408465D0 (en) * 1994-04-27 1994-06-22 Univ Mcgill Apolipoprotein e polymorphism & treatment of alzheimer's disease

Also Published As

Publication number Publication date
FR2765591B1 (fr) 2002-08-09
CA2295865C (fr) 2012-09-04
JP2002510975A (ja) 2002-04-09
DE69825888T2 (de) 2005-11-17
EP0983391A1 (de) 2000-03-08
FR2765591A1 (fr) 1999-01-08
AU8346498A (en) 1999-01-25
JP4358311B2 (ja) 2009-11-04
US6391553B1 (en) 2002-05-21
EP0983391B1 (de) 2004-08-25
WO1999001574A1 (fr) 1999-01-14
CA2295865A1 (fr) 1999-01-14

Similar Documents

Publication Publication Date Title
CY2018020I1 (el) Θεραπεια της νοσου ρομρε
NO981388L (no) Bedring av Dupuytrens sykdom
DE69528011D1 (de) Verfahren zur Pflege der Nägel
NO953262D0 (no) Bedring av Dupuytrens sykdom
EP0906573A4 (de) Methoden zur diagnose der klinischen subtypen von morbus crohn.
NO20001869D0 (no) Fremgangsmõte for behandling av Alzheimerssykdom
DE69825888D1 (de) Diagnostisches verfahren der alzheimer-erkrankung
DE69826951D1 (de) Verfahren zur Gewebepflege
TR199701051A3 (tr) 2' -Fluoro-5-metil- -l-arabino-furanosilüridin hazirlanma prosesi
HUP0003684A3 (en) Diagnostic test for alzheimer's disease
FI954967A0 (fi) Diagnostinen kuvausaine
FR2725023B1 (fr) Diagnostic direct d'haptenes
GB9717142D0 (en) Diagnosis of alzheimer's disease
ITMI981834A0 (it) Diagnosi dell'autismo
GB9323826D0 (en) Diagnosis of alzheimer's disease
FR2766927B1 (fr) Methodes et kits pour le diagnostic de la maladie d'alzheimer
GB9418854D0 (en) Diagnosis of alzheimer's disease
UA25492A (uk) Спосіб лікуваhhя хвороби гіршпруhга
UA25468A (uk) Спосіб визhачеhhя життєздатhості м'язової ткаhиhи
GB9517266D0 (en) Diagnosis of alzheimer's disease
GB9709416D0 (en) Methods for treatment of alzheimer's disease using azaspiranes
LV12282A (lv) Panemiens galvas smadzenu saslimsanu diferencialajai diagnostikai
UA1629S (uk) Набір фестонів "веснянка-5"
SE9901466D0 (sv) Nucleic acids for diagnosing and modeling alzheimer's disease
KR980000689U (ko) 목욕용 때밀이구

Legal Events

Date Code Title Description
8364 No opposition during term of opposition